(Q42518492)

1 November 2017

title

Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo (English)

1 reference

1 November 2017

1 reference

4

1 reference

1 November 2017

Camillo Di Giulio

3

0 references

Marisa Cacchio

series ordinal

2

object named as

Marisa Cacchio

1 reference

1 November 2017

Vincenzo Di Matteo

1

1 reference

1 November 2017

Ennio Esposito

series ordinal

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Pharmacology, Biochemistry and Behavior

1 November 2017

published in

1 reference

1 November 2017

volume

71

1 reference

1 November 2017

issue

4

1 reference

1 November 2017

page(s)

607-613

1 reference

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin 2C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Role of 5-HT(2C) receptors in the control of central dopamine function

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Binding of typical and atypical antipsychotic drugs to multiple neurotransmitter receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900714-6

7 January 2021

10.1016/S0091-3057(01)00714-6

Identifiers

DOI

1 reference

1 November 2017

1 reference